Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adverse events after imatinib mesylate therapy.
Elliott MA, Mesa RA, Tefferi A. Elliott MA, et al. Among authors: mesa ra. N Engl J Med. 2002 Feb 28;346(9):712-3. doi: 10.1056/NEJM200202283460919. N Engl J Med. 2002. PMID: 11870257 No abstract available.
Thalidomide treatment in myelofibrosis with myeloid metaplasia.
Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Elliott MA, et al. Among authors: mesa ra. Br J Haematol. 2002 May;117(2):288-96. doi: 10.1046/j.1365-2141.2002.03443.x. Br J Haematol. 2002. PMID: 11972510 Free article. Clinical Trial.
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Tefferi A, et al. Among authors: mesa ra. Blood. 2002 May 15;99(10):3854-6. doi: 10.1182/blood-2001-12-0154. Blood. 2002. PMID: 11986248 Free article. Clinical Trial.
434 results